Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Multicenter Study

Clinical Trial, Phase III

Comparative Study

Clinical Trial, Phase II

Review

Systematic Review

Observational Study

Clinical Trial

Equivalence Trial

Publication Year

From

Quick links

Individual year

2024

2023

2022

2021

2020

2019

2017

2016

2015

2014

2013

2012

2008

2007

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Nasopharyngitis""[mesh_terms]

24 Results

Searching titles within these results

Comparative safety of different recommended doses of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials.

Lu Chen, Qingxia Xue, Chunyan Yan, Bingying Tang, Lu Wang, Bei Zhang, Quan Zhao

Frontiers in endocrinology 2023;14():1256548

Free Full Text

Abstract

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.

Richard K Bogan, Nancy Foldvary-Schaefer, Roman Skowronski, Abby Chen, Michael J Thorpy

CNS drugs 2023;37(4):323-335

Free Full Text

Abstract

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.

Thomas Philipp, Timothy R Smith, Robert Glazer, Margaret Wernsing, Joseph Yen, James Jin, Helmut Schneider, Rainer Pospiech

Clinical therapeutics 2007;29(4):563-80

Full Text

Abstract

Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses.

Qingying He, Xiao Ma, Xin Xie, Jinhao Zeng, Qian Chen, Jing Guo, Xurui Wang, Wenquan Li, Zongzhou Song

Frontiers in immunology 2024;15():1342810

Free Full Text

Abstract

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.

Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D'Haens, Hiroshi Nakase, Julian Panés, Peter D R Higgins, Pascal Juillerat, James O Lindsay, Edward V Loftus, William J Sandborn, Walter Reinisch, Min-Hu Chen, Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Michael A Weinreich, Remo Panaccione

Lancet (London, England) 2022;399(10341):2113-2128

Full Text

Abstract

Are new variants of psoriasis therapy (IL-17 inhibitors) safe?

Dominika Wcisło-Dziadecka, Agata Kaźmierczak, Beniamin Grabarek, Martyna Zbiciak-Nylec, Ligia Brzezińska-Wcisło

International journal of dermatology 2020;58(12):1360-1365

Full Text

Abstract

The hemostatic efficacy of Ankaferd Blood Stopper in adenoidectomy.

Ismail Iynen, Ferhat Bozkus, Imran San, Necat Alatas

International journal of pediatric otorhinolaryngology 2012;75(10):1292-5

Full Text

Abstract

Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder.

David S Baldwin, Thomas Hansen, Ioana Florea

Current medical research and opinion 2013;28(10):1717-24

Full Text

Abstract

Obeticholic acid in primary biliary cholangitis: where we stand.

Kris V Kowdley, Vignan Manne

Current opinion in gastroenterology 2020;35(3):191-196

Full Text

Abstract

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Marc L Decramer, Nicola A Hanania, Jan O Lötvall, Barbara P Yawn

International journal of chronic obstructive pulmonary disease 2013;8():53-64

Free Full Text

Abstract

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.

Anna G Nilsson, Ragnhildur Bergthorsdottir, Pia Burman, Per Dahlqvist, Bertil Ekman, Britt Edén Engström, Oskar Ragnarsson, Stanko Skrtic, Jeanette Wahlberg, Heinrich Achenbach, Sharif Uddin, Claudio Marelli, Gudmundur Johannsson

European journal of endocrinology 2017;176(6):715-725

Free Full Text

Abstract

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.

Désirée van der Heijde, Xenofon Baraliakos, Lianne S Gensler, Walter P Maksymowych, Vira Tseluyko, Oleg Nadashkevich, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Robin Besuyen, Thijs Hendrikx, Neelufar Mozaffarian, Ke Liu, Joy M Greer, Atul Deodhar, Robert Landewé

Lancet (London, England) 2019;392(10162):2378-2387

Free Full Text

Abstract

Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease.

S Torretta, P Marchisio, V Rinaldi, D Carioli, E Nazzari, L Pignataro

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2017;274(3):1423-1429

Full Text

Abstract

Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial.

Shin Fukudo, Yuka Endo, Michio Hongo, Atsushi Nakajima, Tatsuya Abe, Hiroyuki Kobayashi, Tomohiro Nakata, Toshio Nakajima, Kanako Sameshima, Kohei Kaku

The lancet. Gastroenterology & hepatology 2019;3(9):603-613

Full Text

Abstract

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.

Boni E Elewski, Hector W Cáceres, Liberation DeLeon, Saleh El Shimy, Judy A Hunter, Nicolay Korotkiy, Ingrid Johnson Rachesky, Victoria Sanchez-Bal, Gail Todd, LindaAnn Wraith, Bin Cai, Amir Tavakkol, Rajesh Bakshi, Judit Nyirady, Sheila Fallon Friedlander

Journal of the American Academy of Dermatology 2008;59(1):41-54

Full Text

Abstract

Results: 1 – 15 / 24

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Nasopharyngitis""[mesh_terms]

Comparative safety of different recommended doses of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials.

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.

Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses.

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.

Are new variants of psoriasis therapy (IL-17 inhibitors) safe?

The hemostatic efficacy of Ankaferd Blood Stopper in adenoidectomy.

Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder.

Obeticholic acid in primary biliary cholangitis: where we stand.

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.

Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease.

Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial.

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.

Results for
""Nasopharyngitis""[mesh_terms]